Search Results - G. E. Mazo

Refine Results
  1. 1
    Complications of neuroleptic hyperprolactinaemia

    Complications of neuroleptic hyperprolactinaemia by G. E. Mazo, L. N. Gorobets

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction

    Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction by L. N. Gorobets, G. E. Mazo

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Neuroleptic hyperprolactinemia medicamentous correction

    Neuroleptic hyperprolactinemia medicamentous correction by L. N. Gorobets, G. E. Mazo

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Methods of correction of hyperprolactinemia induced by antipsychotics: current state of the problem and development prospects

    Methods of correction of hyperprolactinemia induced by antipsychotics: current state of the problem and development prospects by G. E. Mazo, Ya. V. Yakovleva

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Mechanisms of formation comorbidity depression and obesity

    Mechanisms of formation comorbidity depression and obesity by G. E. Mazo, A. O. Kibitov

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Replacement of antipsychotics as a method of preventing the formation of resistance in schizophrenia

    Replacement of antipsychotics as a method of preventing the formation of resistance in schizophrenia by G. E. Mazo, L. N. Gorobets

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Risk management of metabolic disorders in the use of antipsychotics

    Risk management of metabolic disorders in the use of antipsychotics by G. E. Mazo, A. O. Kibitov

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Anhedonia as a basic syndrome and a target for treatment for depressive disorder

    Anhedonia as a basic syndrome and a target for treatment for depressive disorder by G. E. Mazo, A. O. Kibitov

    Published 2019-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Cognitive impairments in schizophrenia and their impact on oxidative stress

    Cognitive impairments in schizophrenia and their impact on oxidative stress by A. S. Piatoikina, T. V. Zhilyaeva, G. E. Mazo

    Published 2022-10-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Genetic markers of One-Carbon Metabolism Disorders in Schizophrenial

    Genetic markers of One-Carbon Metabolism Disorders in Schizophrenial by T. V. Zhilyaeva, A. S. Piatoikina, A. S. Blagonravova, G. E. Mazo

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Inflammation as a link between depression and metabolic syndrome

    Inflammation as a link between depression and metabolic syndrome by A. P. Gorbunova, G. V. Rukavishnikov, G. E. Mazo

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Therapeutic resistance in depression from the genetics and pharmacogenetics point of view

    Therapeutic resistance in depression from the genetics and pharmacogenetics point of view by G. E. Mazo, G. V. Rukavishnikov, A. O. Kibitov

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Bipolar affective disorders in epilepsy

    Bipolar affective disorders in epilepsy by G. E. Mazo, L. V. Lipatova, N. E. Zhukov

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Digital phenotyping as a new method of screening for mental disorders

    Digital phenotyping as a new method of screening for mental disorders by E. D. Kasyanov, Ya. V. Kovaleva, G. E. Mazo

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study

    Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study by T. V. Zhilyaeva, A. S. Piatoikina, G. V. Rukavishnikov, G. E. Mazo

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Post-stroke depression: diagnostic difficulties and treatment perspectives

    Post-stroke depression: diagnostic difficulties and treatment perspectives by S. Iu. Maltcev, V. A. Mikhailov, G. E. Mazo, L. V. Lukina

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    High-risk state for psychosis: psychometric screening tools

    High-risk state for psychosis: psychometric screening tools by I. E. Tsarkov, A. E. Novoselova, T. V. Zhilyaeva, G. E. Mazo

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    The role of hematological coefficients of systemic inflammation in the diagnosis and risk assessment of affective disorders

    The role of hematological coefficients of systemic inflammation in the diagnosis and risk assessment of affective disorders by A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Genetic and epigenetic aspects of depression and somatic disorders comorbidityon and somatic disorders comorbidity

    Genetic and epigenetic aspects of depression and somatic disorders comorbidityon and somatic disorders comorbidity by G. V. Rukavishnikov, G. E. Mazo, N. G. Neznanov, A. O. Kibitov

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    New approach to mental disorders systematics: starting point or point of view?

    New approach to mental disorders systematics: starting point or point of view? by N. G. Neznanov, G. V. Rukavishnikov, E. D. Kaysanov, T. V. Zhilyaeva, G. E. Mazo

    Published 2020-10-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: